Clinical trial
A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis
NCT02787083 is registered in ClinicalTrials.gov with Philadelphia Urosurgical Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis
- Lead sponsor
- Philadelphia Urosurgical Associates
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- August 31, 2016
- Completion date
- July 5, 2019
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.